1. Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health. 2. Key Laboratory of Organ Transplantation, Zhejiang Province. 3. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. * These authors contributed equally to this work.
✉ Corresponding author: Shu-Sen Zheng, Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, P.R. China. Phone: 86-571-87236570; Fax: 86-571-87236466. E-mail address: shusenzhengedu.cnMore
Citation:
Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L, Zheng SS. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci 2014; 11(3):268-275. doi:10.7150/ijms.7769. https://www.medsci.org/v11p0268.htm
Background: Metastasis-associated in colon cancer-1 (MACC1) acts as a promoter of tumor metastasis; however, the predictive value of MACC1 for hepatocellular carcinoma (HCC) after liver transplantation (LT) remains unclear.
Methods: We examined the expression of MACC1 and its target genes MET and FAK by quantitative PCR in 160 patients with HCC that was undergone LT.
Results: The patients with MACC1high or FAKhigh in HCCs showed a significantly shorter overall survival and higher cumulative recurrence rates after liver transplantation (LT), compared with MACC1low or FAKlow group. Multivariate analysis indicated that MACC1 alone or combination of MACC1/FAK was an independent prognostic factor for overall survival and cumulative recurrence.
Conclusions: MACC1 or combination of MACC1/FAK could serve as a novel biomarker in predicting the prognosis of HCC after LT.
Gao, S., Lin, B.Y., Yang, Z., Zheng, Z.Y., Liu, Z.K., Wu, L.M., Xie, H.Y., Zhou, L., Zheng, S.S. (2014). Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. International Journal of Medical Sciences, 11(3), 268-275. https://doi.org/10.7150/ijms.7769.
ACS
Gao, S.; Lin, B.Y.; Yang, Z.; Zheng, Z.Y.; Liu, Z.K.; Wu, L.M.; Xie, H.Y.; Zhou, L.; Zheng, S.S. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int. J. Med. Sci. 2014, 11 (3), 268-275. DOI: 10.7150/ijms.7769.
NLM
Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L, Zheng SS. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci 2014; 11(3):268-275. doi:10.7150/ijms.7769. https://www.medsci.org/v11p0268.htm
CSE
Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L, Zheng SS. 2014. Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci. 11(3):268-275.